Bruker Corporation (BRKR)
Automate Your Wheel Strategy on BRKR
With Tiblio's Option Bot, you can configure your own wheel strategy including BRKR - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BRKR
- Rev/Share 22.7315
- Book/Share 12.2111
- PB 3.1443
- Debt/Equity 1.1632
- CurrentRatio 1.57
- ROIC 0.0266
- MktCap 5711241080.0
- FreeCF/Share 1.1517
- PFCF 32.7104
- PE 71.7815
- Debt/Assets 0.3563
- DivYield 0.004
- ROE 0.0441
- Rating B-
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BRKR | Citigroup | Buy | Neutral | -- | $40 | May 22, 2025 |
| Initiation | BRKR | Guggenheim | -- | Buy | -- | $72 | Dec. 19, 2024 |
| Initiation | BRKR | UBS | -- | Neutral | -- | $66 | Dec. 10, 2024 |
| Upgrade | BRKR | Goldman | Sell | Neutral | -- | $60 | Dec. 5, 2024 |
| Initiation | BRKR | Barclays | -- | Overweight | -- | $75 | Oct. 15, 2024 |
| Downgrade | BRKR | Wolfe Research | Outperform | Peer Perform | -- | -- | Sept. 30, 2024 |
| Initiation | BRKR | Wells Fargo | -- | Overweight | -- | $78 | Aug. 28, 2024 |
News
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection
Published: June 03, 2025 by: Business Wire
Sentiment: Neutral
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced that its Applied Mass Spectrometry (Applied MS) division will present a powerful lineup of innovations at the 73rd American Society for Mass Spectrometry (ASMS) Conference, taking place June 1–5, 2025, in Baltimore, Maryland. These developments reflect Bruker's continued investment in applied markets, particularly in therapeutic drug monitoring (TDM), drugs of abuse (DoA) analysis and environmental analysis. Br.
Read More
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics
Published: June 03, 2025 by: Business Wire
Sentiment: Neutral
INNSBRUCK, Austria--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (NASDAQ: BRKR) today announced the acquisition of biocrates life sciences ag, located in Innsbruck, Austria. Financial terms were not disclosed. biocrates is a global leader in mass spectrometry (MS)-based quantitative metabolite and lipid analysis kits, assays, software and services that make standardized metabolomics accessible to laboratories worldwide. The biocrates kits cover over 1,000+ metabolites from more than 40 metabolite classe.
Read More
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics
Published: June 02, 2025 by: Business Wire
Sentiment: Neutral
BALTIMORE--(BUSINESS WIRE)---- $BRKR #BRKR--At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced significant further advances in ultra-high sensitivity 4D-Proteomics™ with the introduction of the timsUltra AIP mass spectrometer. Its innovative, breakthrough Athena Ion Processor (AIP) technology further boosts the extreme sensitivity of timsTOF Ultra PASEF® methods for key biological and clinical research problems with very low sample amounts. N.
Read More
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity
Published: June 02, 2025 by: Business Wire
Sentiment: Neutral
BALTIMORE--(BUSINESS WIRE)---- $BRKR #BRKR--At the 73rd Conference on Mass Spectrometry and Allied Topics (ASMS), Bruker Corporation (Nasdaq: BRKR) today announced the new proteoElute nanoLC system, featuring ceramic valves, proteoTrap trapping columns, and next-generation PepSep Advanced nLC columns, further enhancing robustness, sensitivity and proteome coverage in ultra-sensitive proteomics workflows. A. Bruker Introduces the proteoElute Next-Generation Nanoflow LC System for Robust, Ultra-Sensitive Proteom.
Read More
Bruker Corporation to Present at the Jefferies Global Healthcare Conference
Published: May 30, 2025 by: Business Wire
Sentiment: Neutral
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will participate in the Jefferies Global Healthcare Conference in New York City with a fireside chat presentation scheduled for Wednesday, June 4th, 2025 at 5:30 PM Eastern Time. A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events &.
Read More
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer
Published: May 29, 2025 by: Zacks Investment Research
Sentiment: Positive
BRKR unveils the MOVE-T analyzer to boost quality and efficiency in the dairy industry, setting new standards for precision and reliability.
Read More
International Markets and Bruker (BRKR): A Deep Dive for Investors
Published: May 13, 2025 by: Zacks Investment Research
Sentiment: Neutral
Explore Bruker's (BRKR) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Read More
Bruker Q1 Earnings & Revenues Top Estimates, Stock Up, Margins Crash
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker delivers better-than-expected earnings and revenues in the first quarter of 2025.
Read More
Bruker Corporation (BRKR) Q1 2025 Earnings Call Transcript
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Neutral
Bruker Corporation (NASDAQ:BRKR ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Joe Kostka – Director-Investor Relations Frank Laukien – President and Chief Executive Officer Gerald Herman – Executive Vice President and Chief Financial Officer Conference Call Participants Puneet Souda – Leerink Partners Michael Ryskin – BoA Patrick Donnelly – Citi Tycho Peterson – Jefferies Rachel Vatnsdal – JP Morgan Luke Sergott – Barclays Subbu Nambi – Guggenheim Doug Schenkel – Wolfe Research Operator Good day, and welcome to the Bruker Corporation First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode.
Read More
Compared to Estimates, Bruker (BRKR) Q1 Earnings: A Look at Key Metrics
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Bruker (BRKR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Bruker (BRKR) Surpasses Q1 Earnings and Revenue Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker (BRKR) came out with quarterly earnings of $0.47 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.53 per share a year ago.
Read More
Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Negative
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Bruker Stock May Benefit Following Its Investment in Ridom GmbH
Published: April 14, 2025 by: Zacks Investment Research
Sentiment: Positive
BRKR announces a new partnership with NGS bioinformatics solution provider Ridom GmbH.
Read More
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain?
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
BRKR's latest innovation offers 1H NMR and a choice of 15 X-nuclei with just one click.
Read More
Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up
Published: April 08, 2025 by: Zacks Investment Research
Sentiment: Positive
BRKR's new 1.3 GHz high-resolution NMR system comes with a stable, standard-bore 54 mm superconducting magnet.
Read More
Bruker Stock to Benefit From the Launch of X4 POSEIDON Benchtop XRM
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Positive
BRKR unveils X4 POSEIDON advanced XRM for 3D microscopy in industrial and scientific applications.
Read More
Bruker Launches X4 POSEIDON™ Advanced X-Ray Microscope for Three-Dimensional Microscopy in Industrial and Scientific Applications
Published: February 27, 2025 by: Business Wire
Sentiment: Neutral
KONTICH, Belgium--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative benchtop XRM system offers advanced capabilities comparable to larger, floor-standing systems to make high-resolution 3D X-ray microscopy accessible for demanding XRM applications in industrial applications and scientific research. The X4 POSEIDON features a high-end X-ray.
Read More
Bruker Corporation to Present at Upcoming Investor Conferences
Published: February 20, 2025 by: Business Wire
Sentiment: Neutral
BILLERICA, Mass.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today that its senior leadership will present at the following conferences: Citi 2025 Unplugged Medtech and Life Sciences Access Day in New York City Thursday, February 27, 2025, at 2:30 p.m. Eastern Time TD Cowen 45th Annual Health Care Conference in Boston, MA Wednesday, March 5, 2025, at 11:10 a.m. Eastern Time Barclays 27th Annual Global Healthcare Conference in Miami, FL Tuesday, March 11, 2025, at 2:30 p.m. Eas.
Read More
Bruker Q4 Earnings & Revenues Surpass Estimates, Stock Falls
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Bruker delivers better-than-expected earnings and revenues in the fourth quarter of 2024.
Read More
Bruker Corporation (BRKR) Q4 2024 Earnings Call Transcript
Published: February 13, 2025 by: Seeking Alpha
Sentiment: Neutral
Bruker Corporation (NASDAQ:BRKR ) Q4 2024 Results Conference Call February 13, 2025 8:30 AM ET Company Participants Joe Kostka - Director, Investor Relations Frank Laukien - President and CEO Gerald Herman - Executive Vice President and CFO Conference Call Participants Puneet Souda - Leerink Partners Elizabeth Speyer - Citigroup Salem Salem - Barclays Brandon Couillard - Wells Fargo Madeline Mollman - Wolfe Research Tycho Peterson - Jefferies Subbu Nambi - Guggenheim Securities Operator Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Read More
Bruker (BRKR) Reports Q4 Earnings: What Key Metrics Have to Say
Published: February 13, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Bruker (BRKR) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
About Bruker Corporation (BRKR)
- IPO Date 2000-08-04
- Website https://www.bruker.com
- Industry Medical - Devices
- CEO Dr. Frank H. Laukien Ph.D.
- Employees 11396